P2X3 receptors and sensitization of autonomic reflexes

被引:25
|
作者
Ford, Anthony P. [1 ]
Undem, Bradley J. [2 ]
Birder, Lori A. [3 ]
Grundy, David [4 ]
Pijacka, Wioletta [5 ]
Paton, Julian F. R. [5 ]
机构
[1] Afferent Pharmaceut, San Mateo, CA 94403 USA
[2] Johns Hopkins Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21224 USA
[3] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA
[4] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
[5] Univ Bristol, Sch Physiol & Pharmacol, Bristol CardioVasc, Bristol BS8 1TD, Avon, England
来源
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL | 2015年 / 191卷
关键词
Sensitization; Hyperreflexia; Airway hyperreactivity; Bladder; Gastrointestinal; Autonomic; Carotid hypertonicity; P2X3; receptors; Sympathetic activity; BLADDER UMBRELLA CELLS; PURINERGIC NEUROMUSCULAR-TRANSMISSION; INTESTINAL AFFERENT HYPERSENSITIVITY; CAROTID-BODY CHEMORECEPTORS; ENTERIC NERVOUS-SYSTEM; PIG DISTAL COLON; SMOOTH-MUSCLE; URINARY-BLADDER; P2X(7) RECEPTOR; SENSORY NEURONS;
D O I
10.1016/j.autneu.2015.04.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A great deal of basic and applied physiology and pharmacology in sensory and autonomic neuroscience has teased apart mechanisms that drive normal perception of mechanical, thermal and chemical signals and convey them to CNS, the distinction of fiber types and receptors and channels that mediate them, and how they may become dysfunctional or maladaptive in disease. Likewise, regulation of efferent autonomic traffic to control organ reflexes has been well studied. In both afferent and efferent limbs, a wide array of potential therapeutic mechanisms has surfaced, some of which have progressed into clinic, if not full regrastration. One conversation that has been less well progressed relates to how the afferent limb and its sensitization shapes the efferent outputs, and where modulation may offer new therapeutic avenues, especially for poorly addressed and common signs and symptoms of disease. Therapeutics for CV disease (HF, hypertension), respiratory disease (asthma, COPD), urological disease (OAB), GI disease (IBS), and inter alia, have largely focused on the efferent control of effector cells to modulate movement, contraction and secretion; medicinal needs remain with limits to efficacy, AEs and treatment resistance being common. We now must turn, in the quest for improved therapeutics, to understand how sensation from these organs becomes maladapted and sensitized in disease, and what opportunities may arise for improved therapeutics given the abundance of targets, many pharmacologically untapped, on the afferent side. One might look at the treatment resistant hypertension and the emerging benefit of renal denervation; or urinary bladder overactivity/neurogenic bladder and the emergence of neuromodulation, capsaicin instillation or botox injections to attenuate sensitized reflexes, as examples of merely the start of such progress. This review examines this topic more deeply, as applies to four major organ systems all sharing a great need from unsatisfied patients. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 50 条
  • [31] Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors with in vivo efficacy in a pain model
    Ballini, E.
    Virginio, C.
    Medhurst, S. J.
    Summerfield, S. G.
    Aldegheri, L.
    Buson, A.
    Carignani, C.
    Chen, Y. H.
    Giacometti, A.
    Lago, I.
    Powell, A. J.
    Jarolimek, W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) : 1315 - 1325
  • [32] Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation
    Richards, David
    Gever, Joel R.
    Ford, Anthony P.
    Fountain, Samuel J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (13) : 2279 - 2291
  • [33] Overexpression of P2X3 and P2X7 Receptors and TRPV1 Channels in Adrenomedullary Chromaffin Cells in a Rat Model of Neuropathic Pain
    Arribas-Blazquez, Marina
    Alcides Olivos-Ore, Luis
    Victoria Barahona, Maria
    Sanchez de la Muela, Mercedes
    Solar, Virginia
    Jimenez, Esperanza
    Gualix, Javier
    McIntosh, J. Michael
    Ferrer-Montiel, Antonio
    Teresa Miras-Portugal, Maria
    Artalejo, Antonio R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (01):
  • [34] Puerarin alleviates burn-related procedural pain mediated by P2X3 receptors
    Li, Xin
    Zhang, Jun
    Gao, Yun
    Yang, Yang
    Xu, Changshui
    Li, Guilin
    Guo, Guanghua
    Liu, Shuangmei
    Xie, Jinyan
    Liang, Shangdong
    PURINERGIC SIGNALLING, 2011, 7 (04) : 489 - 497
  • [35] Increased temperature and acidosis effectively accelerate the recovery of P2X3 receptors from desensitization
    O. Maximyuk
    V. Khmyz
    O. Krishtal
    Neurophysiology, 2007, 39 : 330 - 331
  • [36] Puerarin alleviates burn-related procedural pain mediated by P2X3 receptors
    Xin Li
    Jun Zhang
    Yun Gao
    Yang Yang
    Changshui Xu
    Guilin Li
    Guanghua Guo
    Shuangmei Liu
    Jinyan Xie
    Shangdong Liang
    Purinergic Signalling, 2011, 7 : 489 - 497
  • [37] Novel Peptide from Spider Venom Inhibits P2X3 Receptors and Inflammatory Pain
    Grishin, Eugene V.
    Savchenko, Ganna A.
    Vassilevski, Alexander A.
    Korolkova, Yuliya V.
    Boychuk, Yaroslav A.
    Viatchenko-Karpinski, Viacheslav Y.
    Nadezhdin, Kirill D.
    Arseniev, Alexander S.
    Pluzhnikov, Kirill A.
    Kulyk, Vyacheslav B.
    Voitenko, Nana V.
    Krishtal, Oleg O.
    ANNALS OF NEUROLOGY, 2010, 67 (05) : 680 - 683
  • [38] P2X3 receptor gating near normal body temperature
    V. Khmyz
    O. Maximyuk
    V. Teslenko
    A. Verkhratsky
    O. Krishtal
    Pflügers Archiv - European Journal of Physiology, 2008, 456 : 339 - 347
  • [39] Inhibitory effect of estrogen receptor beta on P2X3 receptors during inflammation in rats
    Jiang, Qian
    Li, Wen-xin
    Sun, Jia-run
    Zhu, Tian-tian
    Fan, Juan
    Yu, Li-hua
    Burnstock, Geoffrey
    Yang, Hua
    Ma, Bei
    PURINERGIC SIGNALLING, 2017, 13 (01) : 105 - 117
  • [40] AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist
    Gever, Joel R.
    Soto, Rothschild
    Henningsen, Robert A.
    Martin, Renee S.
    Hackos, David H.
    Panicker, Sandip
    Rubas, Werner
    Oglesby, Ian B.
    Dillon, Michael P.
    Milla, Marcos E.
    Burnstock, Geoffrey
    Ford, Anthony P. D. W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (06) : 1387 - 1398